Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone

Uveal Melanoma Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00351728
• Other study ID #: UCLA IRB #05-04-016
• Status: Completed
• Phase: N/A
• First received: July 12, 2006
• Last updated: July 5, 2016
• Start date: June 2006
• Est. completion date: August 2012

Study information

• Verified date: July 2016
• Source: Jonsson Comprehensive Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

Patients diagnosed with ocular melanoma consent to participate in the study. Combined PET/CT scans of the whole body are performed at baseline, three months later, and six months after that for a total of three combined scans in the first year. Subsequently, these combined scans will be performed at 6-monthly intervals for a total of two combined scans per year.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 174
• Est. completion date: August 2012
• Est. primary completion date: August 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Patients with a diagnosis of ocular melanoma (a pigmented malignant tumor) involving the choroid and/or ciliary body (the blood vessel layer in the back of the eye and/or the part of the eye behind the iris).

2. Patients 18 years of age or older.

3. Patients able to give informed consent.

Exclusion Criteria:

1. Patients who refuse to participate in the study.

2. Patients who are unable to cooperate with or cannot undergo PET/CT scanning.

3. Patients who will be moving out of the area of UCLA during the ten years of this study.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Choroidal Melanoma
• Melanoma
• Ocular Melanoma
• Uveal Melanoma

Locations

Country	Name	City	State
United States	Jules Stein Eye Institute	Los Angeles	California

Sponsors (1)

Lead Sponsor	Collaborator
Jonsson Comprehensive Cancer Center

Country where clinical trial is conducted

United States,